Your session is about to expire
← Back to Search
RTX-GRT7039 Injection for Osteoarthritis
Study Summary
This trial tests if a single injection of a new drug can reduce pain from knee osteoarthritis when other treatments fail.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have tried the usual treatments for your pain, but they did not work well enough for you.You have certain existing bone conditions or severe knee pain that is not caused by osteoarthritis.You have hip osteoarthritis on the same side as your knee condition.You have pain near a joint, but it's not caused by osteoarthritis or other common conditions like bursitis or tendonitis.You have other health conditions that may affect the evaluation of your knee during the trial.You have had an allergic reaction to resiniferatoxin (RTX) or similar substances found in capsaicin or chili peppers.
- Group 1: RTX-GRT7039
- Group 2: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the drug RTX-GRT7039 been authorized by the United States Food and Drug Administration?
"The safety of RTX-GRT7039 is assessed as a 3 due to the prior clinical data gathered in Phase 3 trials that demonstrate efficacy and back up its overall security."
Are there a multitude of healthcare facilities running this investigation within the state?
"Presently, the trial is being administered from 25 separate clinics. These sites are spread across Cerritos, Santa Barbara and Miami in addition to 22 other locations. For participants' convenience, it is advisable that they select a clinic closest to them when enrolling as this will reduce travel costs."
How many participants can this experiment accommodate?
"Grünenthal GmbH, the trial's sponsor, requires 450 participants that meet their study criteria to run it successfully. The clinical research will be conducted at Tucson Orthopaedic Research Center in Cerritos, California and Core Health Care Group located in Santa Barbara, Florida."
Is this trial currently accepting new participants?
"Affirmative. Clinicaltrials.gov presents evidence that this clinical trial is looking for volunteers, with the original posting date on August 26th 2022 and a recent update on February 23rd 2023. 450 individuals are desired across 25 sites."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger